Hypertrophic cardiomyopathy is the most common inherited cardiovascular disease. It is characterized by increased ventricular wall thickness and is highly complex due to its heterogeneous clinical presentation, several phenotypes, large number of associated causal mutations and broad spectrum of complications. It is caused by mutations in sarcomeric proteins, which are identified in up to 60% of cases of the disease. Clinical manifestations of Hypertrophic Cardiomyopathy include shortness of breath, chest pain, palpitations and syncope, which are related to the onset of diastolic dysfunction, left ventricular outflow tract obstruction, ischemia, atrial fibrillation and abnormal vascular responses. It is associated with an increased risk of sudden cardiac death, heart failure and thromboembolic events. In this article, we discuss the diagnostic and therapeutic aspects of this disease.
Keywords: Diagnóstico genético; Genetic diagnosis; Hypertrophic cardiomyopathy; Miocardiopatía hipertrófica; Muerte súbita cardiaca; Mutaciones sarcoméricas; Sarcomeric mutations; Sudden cardiac death; Therapy; Tratamiento.
Copyright © 2017 Elsevier España, S.L.U. All rights reserved.